Clinical Trials

Clinical Trial: Endocrine Response in Pre-Surgical ILC Patients

Postmenopausal women who have been diagnosed with invasive lobular breast cancer (ILC) who have not yet had surgery to remove their tumor may be eligible to participate in a multi-site clinical trial. This clinical trial will compare how lobular breast tumors respond to three different commonly prescribed, effective medications that are currently being used to treat breast cancer. 

Clinical Trial: Endocrine Response in Pre-Surgical ILC Patients Read More »

Pelops trial information with words "completed enrollment"

PELOPS: Clinical Trial with Palbociclib for Pre-surgical ILC Patients

Women who have been diagnosed with Stage 1 – 3 invasive lobular breast cancer (ILC) who have not yet had surgery to remove their tumor may be eligible to participate in a clinical trial.  This trial is open to all ER+ and/or PR+ HER2- patients (ductal or lobular), however it is being enriched with lobular breast cancer patients to promote a better understanding of how ILC might respond differently to these therapies.

PELOPS: Clinical Trial with Palbociclib for Pre-surgical ILC Patients Read More »

Scroll to Top

Join Us

Subscribe for the Latest News & Updates​

  • This field is for validation purposes and should be left unchanged.